Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Yayrí C, Prieto"'
Autor:
Yayrí C. Prieto, Aileen Batte, Milaid Granadillo, Miladys Limonta, Isis Torrens, Enma Brown, Dinorah Torres, Dayana Soler, Laura Varas, Alain B. Alfonso
Publikováno v:
Journal of Cellular Immunotherapy, Vol 4, Iss 2, Pp 71-74 (2018)
Cervical cancer is the second leading cause of cancer death in women. It is well established that human papillomavirus (HPV) is the cause of virtually 100% of these cancers, 70% of which are attributable to infections with HPV types 16 or 18. We deve
Autor:
Rosalina Carballo, José Suárez, Dayana Soler, Aileen Batte, Nelson Merino, Maelys Miyares, Miladys Limonta, Lizet Aldana, Aracelys Blanco, Milaid Granadillo, Isis Torrens, Laura Varas, Yayrí C. Prieto, Alain B. Alfonso, Bárbara González
Publikováno v:
Clinical & Experimental Metastasis. 34:241-249
One important goal of cancer immunotherapy is to prevent and treat tumor metastasis. We have previously reported the significant antitumor effect induced by the immunization with our human papillomavirus therapeutic protein-based vaccine (LALF32-51-E
Autor:
Milaid, Granadillo, Aileen, Batte, Aracelys, Blanco, Alain B, Alfonso, José, Suárez, Nelson, Merino, Rosalina, Carballo, Bárbara O, González, Yayrí C, Prieto, Laura, Varas, Dayana, Soler, Miladys, Limonta, Maelys, Miyares, Lizet, Aldana, Isis, Torrens
Publikováno v:
Clinicalexperimental metastasis. 34(3-4)
One important goal of cancer immunotherapy is to prevent and treat tumor metastasis. We have previously reported the significant antitumor effect induced by the immunization with our human papillomavirus therapeutic protein-based vaccine (LALF
Autor:
Yayrí C. Prieto, Enrique Iglesias, Daymir García, Jorge Sánchez, Gabriel Márquez, Lian Trimiño, Darien García, Yordanka Soria
Publikováno v:
International immunopharmacology. 12(3)
Previous studies showed that simultaneous immunization through the nasal (IN) and subcutaneous (SC) route of a multiantigenic formulation induced a Th1 anti-HIV humoral and cellular immune responses. The formulation was comprised of a recombinant pro
Autor:
Alain B. Alfonso, Aileen Batte, Enma Brown, Yordanka Soria, Yayrí C. Prieto, Laura Varas, Maribel G. Vallespi, Miladys Limonta, Milaid Granadillo, Isis Torrens
Publikováno v:
Journal of Cellular Immunotherapy. (1):44-51
Aluminum-containing adjuvants (alum) continue to be the most widely used adjuvants. It is common knowledge that these adjuvants predominantly induce humoral immunity, but some reports also describe their role combined with IL-12 in the induction of a